Setbacks for blood substitute companies.
D001709:Biotechnology / Q000191:economics* / Q000639:trends*; D001802:Blood Substitutes / Q000191:economics*; D002170:Canada; D017277:Drug Approval; D004465:Economic Competition; D014481:United States
D001802:Blood Substitutes